DENVER, CO--(Marketwire - Mar 14, 2013) - The Pulse Beverage Corporation (OTCQB: PLSB) ("Pulse"), makers of PULSE® brand of functional beverages and Cabana™ 100% Natural Lemonade today announced securing product placement for Cabana™ in 440 Walgreens stores which puts Pulse over 9,000 retail chain stores that it has secured listings for over the past few months. Walgreens is the largest drug retailing chain in the United States. A total of 90 stores are located in Cleveland, serving a population of more than two million; 100 stores are located in the Dallas/Fort Worth metro area, serving a population of more than seven million; and 250 stores are located in Southern California, serving a population of more than twenty two million.
Bob Yates, CEO of Pulse, said, "This is an ongoing rapid trend to procure product placement for our Cabana™ 100% Natural Lemonade in large national retail chains located in highly populated regional areas. Cabana™ will be placed in the cold box section and the dry shelf areas of these Walgreens stores. We are very pleased to be associated with a high quality company such as Walgreens. With the addition of Walgreens and many other well-known chain stores, we are ahead of our target for Q1 of 2013. At this point last year we did not have any listings secured. We expect many more listings in the coming weeks ahead."
About The Pulse Beverage Corporation
The Pulse Beverage Corporation is an emerging growth beverage company that manufactures and distributes Cabana™ 100% Natural Lemonade and PULSE® brand of functional beverages, originally developed by a major healthcare company, in three health platforms: Pulse® Heart Health Formula™, Pulse® Women's Health Formula™ and Pulse® Men's Health Formula™. For more information visit: www.pulsebeverage.com or email email@example.com.
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, regulatory incentives, the development of new business opportunities, and projected costs, revenue, profits and results operations. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.